About this trial
This observational study will examine newly activated cochlear implant users and determine whether their abilities to discern simple sounds change and relate to improved speech perception. Take-home computers and test-equipment will be sent home, and subjects will complete approximately 25 test sessions over the first 3 months of cochlea implant use. Then, subjects will be tested 3 more times in the laboratory until 1 year-post activation. The primary objective is to determine and quantify how sounds change and speech perception improves over the course of early cochlear implant use.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Postlingually deaf cochlear implant users
severe or profound hearing loss
who do not have other diagnoses communicative or cognitive disorders.
Test population: no prior experience with cochlear implants (recruitment happens prior to cochlear implantation).
Disqualifiers
Diagnosed cognitive or communicative disorders (other than deafness)
Below 18 years of age
Above the age of 85 years old.
Trial population
The population includes hearing impaired adults. Both genders will be recruited. All subjects will be recruited from the NYU Cochlear Implant Clinic.
Trial design
Case-control
Prospective
Treatments tested in this trial
Take home tests
Other interventionThese tests will test the discriminability of sounds that vary systematically along the frequency and temporal dimensions of sound. Over the course of the 3 months post-activation, subjects will self-complete "take-home" tests at location of their choosing. Each test session will include the entire test-battery will be repeated frequency as often as every day and then reducing frequency of testing corresponding to the rate of speech perception improvement.
Treatment groups
Trial outcomes
Primary outcomes
Change in percentage of correct responses during speech perception tests
Speech perception tests involves presentation of a speech stimulus (may be a word, sentence, nonsense words, or other speech sounds) and subjects will have to indicate what they heard. The total score is the percentage of speech stimulus correctly understood, ranging from 0-100%.
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
NYU Langone Health
Lead sponsor
National Institute on Deafness and Other Communication Disorders (NIDCD)
Collaborator